{
    "Inclusion Criteria": [
        "Age 18 years old or older",
        "Onset of septic shock within 12 hours"
    ],
    "Exclusion Criteria": [
        "Systemic corticosteroid therapy within the last 3 months before septic shock",
        "High-dose steroid therapy",
        "Immunosuppression",
        "Pregnant",
        "Known glucose-6 phosphate dehydrogenase (G-6PD) deficiency",
        "Known hemachromatosis",
        "Known allergy to vitamin C, hydrocortisone, or thiamine",
        "Anticipated death from a preexisting disease within 90 days after randomization (as determined by the enrolling physician)",
        "Refusal of the attending staff or patient family"
    ],
    "Treatments": [
        {
            "label": "Vitamin C,thiamine,hydrocortisone",
            "type": "EXPERIMENTAL",
            "description": "The combination of vitamin C, thiamine, hydrocortisone :\n\nVitamin C 2g every 6 hours x 5-days Thiamine 200mg every 12 hours x 5-days Hydrocortisone 200mg as a continuous infusion x 5-days",
            "interventionNames": [
                "Drug: Vitamin C,thiamine,hydrocortisone"
            ],
            "Participant Group/Arm": "EXPERIMENTAL:Vitamin C,thiamine,hydrocortisone\nThe combination of vitamin C, thiamine, hydrocortisone :\n\nVitamin C 2g every 6 hours x 5-days Thiamine 200mg every 12 hours x 5-days Hydrocortisone 200mg as a continuous infusion x 5-days",
            "Intervention/Treatment": "DRUG:Vitamin C,thiamine,hydrocortisone\nVitamin C (2g) will be diluted in 100ml 0.9%NACL and administered ivd every 6 hours for 5 days or until participant is discharged from the ICU.\n\nThiamine(200mg) will be diluted in 100ml 0.9%NACL and administered ivd every 12 hours for 5 days or until participant is discharged from the ICU. Hydrocortisone was administered 200 mg/d as a continuous infusion for 5 days or until participant is discharged from the ICU.",
            "intervention_dict": {
                "type": "DRUG",
                "name": "Vitamin C,thiamine,hydrocortisone",
                "description": "Vitamin C (2g) will be diluted in 100ml 0.9%NACL and administered ivd every 6 hours for 5 days or until participant is discharged from the ICU.\n\nThiamine(200mg) will be diluted in 100ml 0.9%NACL and administered ivd every 12 hours for 5 days or until participant is discharged from the ICU. Hydrocortisone was administered 200 mg/d as a continuous infusion for 5 days or until participant is discharged from the ICU.",
                "armGroupLabels": [
                    "Vitamin C,thiamine,hydrocortisone"
                ],
                "otherNames": [
                    "Ascorbic Acid",
                    "Vitamin B1"
                ]
            }
        },
        {
            "label": "Placebo",
            "type": "PLACEBO_COMPARATOR",
            "description": "Normal Saline Solution (0.9%NaCl) in a volume to match all experimental arm components",
            "interventionNames": [
                "Drug: Placebo"
            ],
            "Participant Group/Arm": "PLACEBO_COMPARATOR:Placebo\nNormal Saline Solution (0.9%NaCl) in a volume to match all experimental arm components",
            "Intervention/Treatment": "DRUG:Placebo\nNormal saline (0.9% NaCl solution) volume to match all components",
            "intervention_dict": {
                "type": "DRUG",
                "name": "Placebo",
                "description": "Normal saline (0.9% NaCl solution) volume to match all components",
                "armGroupLabels": [
                    "Placebo"
                ],
                "otherNames": [
                    "Normal saline"
                ]
            }
        }
    ],
    "Primary Outcome Measures": [
        {
            "Outcome Measure": "90-day mortality",
            "Measure Description": "Death from any cause at 90 days after the onset of septic shock",
            "Time Frame": "90 days after randomization"
        }
    ],
    "Secondary Outcome Measures": [
        {
            "Outcome Measure": "ICU mortality",
            "Measure Description": "All-cause mortality at ICU discharge",
            "Time Frame": "90 days after randomization"
        },
        {
            "Outcome Measure": "Hospital mortality",
            "Measure Description": "All-cause mortality at hospital discharge",
            "Time Frame": "90 days after randomization"
        },
        {
            "Outcome Measure": "28-day mortality",
            "Measure Description": "Death from any cause at 28 days after the onset of septic shock",
            "Time Frame": "28 days after randomization"
        }
    ]
}